Literature DB >> 30701210

Liver transplantation for hepatocellular carcinoma: alpha-fetoprotein should be included in selection criteria.

Hans-Christian Pommergaard1.   

Abstract

Entities:  

Year:  2018        PMID： 30701210      PMCID： PMC6327170          DOI： 10.21037/tgh.2018.12.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  17 in total

1.  EASL Clinical Practice Guidelines: Liver transplantation.

Authors: 
Journal:  J Hepatol       Date:  2015-11-17       Impact factor: 25.083

2.  Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.

Authors:  M Ravaioli; G L Grazi; F Piscaglia; F Trevisani; M Cescon; G Ercolani; M Vivarelli; R Golfieri; A D'Errico Grigioni; I Panzini; C Morelli; M Bernardi; L Bolondi; A D Pinna
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

3.  Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.

Authors:  Francis Y Yao; Neil Mehta; Jennifer Flemming; Jennifer Dodge; Bilal Hameed; Oren Fix; Ryutaro Hirose; Nicholas Fidelman; Robert K Kerlan; John P Roberts
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

4.  Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Authors:  Gerd Otto; Sascha Herber; Michael Heise; Ansgar W Lohse; Christian Mönch; Fernando Bittinger; Maria Hoppe-Lotichius; Marcus Schuchmann; Anja Victor; Michael Pitton
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

5.  Liver-allocation policies for patients affected by HCC in Europe.

Authors:  Luciano De Carlis; Stefano Di Sandro; Leonardo Centonze; Andrea Lauterio; Vincenzo Buscemi; Riccardo De Carlis; Fabio Ferla; Raffaella Sguinzi; Stefano Okolicsanyi; Luca Belli; Mario Strazzabosco
Journal:  Curr Transplant Rep       Date:  2016-10-07

6.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

7.  Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.

Authors:  Bilal Hameed; Neil Mehta; Gonzalo Sapisochin; John P Roberts; Francis Y Yao
Journal:  Liver Transpl       Date:  2014-07-12       Impact factor: 5.799

8.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.

Authors:  Christophe Duvoux; Françoise Roudot-Thoraval; Thomas Decaens; Fabienne Pessione; Hanaa Badran; Tullio Piardi; Claire Francoz; Philippe Compagnon; Claire Vanlemmens; Jérome Dumortier; Sébastien Dharancy; Jean Gugenheim; Pierre-Henri Bernard; René Adam; Sylvie Radenne; Fabrice Muscari; Filomena Conti; Jean Hardwigsen; Georges-Philippe Pageaux; Olivier Chazouillères; Ephrem Salame; Marie-Noelle Hilleret; Pascal Lebray; Armand Abergel; Marilyne Debette-Gratien; Michael D Kluger; Ariane Mallat; Daniel Azoulay; Daniel Cherqui
Journal:  Gastroenterology       Date:  2012-06-29       Impact factor: 22.682

9.  Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.

Authors:  Francesco D'Amico; Myron Schwartz; Alessandro Vitale; Parissa Tabrizian; Sasan Roayaie; Swan Thung; Maria Guido; Juan del Rio Martin; Thomas Schiano; Umberto Cillo
Journal:  Liver Transpl       Date:  2009-10       Impact factor: 5.799

10.  Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.

Authors:  Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2016-02-26       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.